← Evidence map

ArticleAntiviral research2022

Repurposing of HIV/HCV protease inhibitors against SARS-CoV-2 3CL

Ling Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36155070